solifenacin succinate has been researched along with Ureteral Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YB; Gao, L; Jiang, Q; Luo, RT; Ran, K | 1 |
| El-Nahas, AR; Elsaadany, M; Gaballah, MA; Mosbah, A; Tharwat, M | 1 |
| Jin, T; Li, H; Liao, B; Liu, J; Liu, Q; Luo, D; Wang, K; Zhang, R; Zhou, L | 1 |
1 review(s) available for solifenacin succinate and Ureteral Diseases
| Article | Year |
|---|---|
Tamsulosin Monotherapy Is Effective in Reducing Ureteral Stent-related Symptoms: A Meta-analysis of Randomized Controlled Studies.
Topics: Adrenergic alpha-1 Receptor Antagonists; Drug Therapy, Combination; Female; Humans; Lower Urinary Tract Symptoms; Male; Randomized Controlled Trials as Topic; Solifenacin Succinate; Stents; Tamsulosin; Treatment Outcome; Ureteral Diseases; Urological Agents | 2019 |
2 trial(s) available for solifenacin succinate and Ureteral Diseases
| Article | Year |
|---|---|
A randomized controlled trial comparing alpha blocker (tamsulosin) and anticholinergic (solifenacin) in treatment of ureteral stent-related symptoms.
Topics: Adrenergic alpha-Antagonists; Adult; Cholinergic Antagonists; Female; Humans; Male; Middle Aged; Postoperative Complications; Solifenacin Succinate; Stents; Sulfonamides; Tamsulosin; Ureteral Diseases | 2016 |
Combination therapy only shows short-term superiority over monotherapy on ureteral stent-related symptoms - outcome from a randomized controlled trial.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Combined Modality Therapy; Drug Therapy, Combination; Female; Humans; Male; Muscarinic Antagonists; Postoperative Complications; Solifenacin Succinate; Stents; Sulfonamides; Tamsulosin; Time Factors; Treatment Outcome; Ureteral Diseases | 2016 |